pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.

Clinical Trials 75

Clinical Trials Clinical Trials Trials Regulation 75

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.

Clinical Trials 89

Clinical Trials Clinical Trials Trials Clinical Research 89

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 17, 2024

The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.

Pharma Companies 155

Pharma Companies Branding Marketing Clinical Trials 155

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. Designing and generating a synthetic control arm.

Clinical Trials 87

Clinical Trials Clinical Trials Trials Engineer 87

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Data security: The clinical trial data is backed-up and secure.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 11, 2023

The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]

Pharma Companies 137

Pharma Companies Licensing Licensing Sales 137

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2023

The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.

Medicine 147

Medicine Development Pharma Companies Clinical Trials 147

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 12, 2023

Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharma companies in the country have increasingly made a shift to nutritional based prescription and over the counter products.

Packaging 142

Packaging Packaging Pharmacy Pharma Companies 142

Pharmaceutical Technology

FEBRUARY 24, 2023

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. BetterLife conducts patient centric study via a fully remote clinical trial. Source link.

In-Vitro 52

In-Vitro Clinical Trials Clinical Trials Trials 52

pharmaphorum

JANUARY 17, 2022

The adoption of decentralised activities was a major factor in allowing clinical trials to continue during the early stages of the pandemic. Ben Hargreaves examines whether this adoption looks set to become a permanent feature of clinical trials moving into the future, rather than just supplying the tools to a temporary need.

Trials 101

Trials Clinical Trials Clinical Trials Clinical Research 101

VirTrial

JANUARY 10, 2020

The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies. The company was selected for its industry leading Virtual Care Management (VCM) program.

Clinical Trials 97

Clinical Trials Clinical Trials Clinical Research Pharma Companies 97

XTalks

JANUARY 15, 2024

The field of clinical research will witness significant advancements in 2024. Read on to learn about the top 10 clinical trial trends for 2024, and be sure to explore and join upcoming webinars about clinical trials at Xtalks. percent from 2023 to 2033.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

pharmaphorum

FEBRUARY 4, 2022

Last year, Bayer launched a project to explore the use of artificial intelligence in clinical trials, working with Finland’s Aalto University to find ways to use the technology to support decentralised trials and streamline the testing process.

Trials 67

Trials Clinical Trials Clinical Trials Pharma Companies 67

Drug Discovery World

JANUARY 24, 2023

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 However, it also made great strides in proving the success of these sorts of trials.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

pharmaphorum

JANUARY 24, 2022

” Those trials also need to be large, involve a diverse range of individuals, and able to be run at reduced cost, said Landray. Protas will design and run smart clinical trials through collaborations with charities, foundations, academic research teams and industry partners, and will take on both repurposed and experimental drugs.

Trials 80

Trials Drugs Clinical Trials Clinical Trials 80

VirTrial

SEPTEMBER 21, 2020

The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharma companies.?. 2020 Accolades. 2018 & 2019 Achievements.

Life Science 52

Life Science Clinical Research Coordinator Pharma Companies Clinical Research 52

XTalks

DECEMBER 20, 2023

‘No Time to Wait’ Ad Campaign from BMS-Pfizer Features Basketball Legend Kareem Abdul-Jabbar for AFib Awareness As pharma TV advertising remained popular in 2023, so did partnerships between pharma companies and celebrities for disease and drug campaigns.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

JULY 7, 2022

But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track. Phesi’s Dr Gen Li: new approaches to clinical trials in cancer.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

MARCH 2, 2022

Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharma companies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

Life Science 95

Life Science Clinical Trials Clinical Trials Trials 95

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. “The Saama Technologies, Inc. , Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

AUGUST 31, 2021

Christopher Boone, global head of health economics and outcomes research at AbbVie, advises: “Evidence generation in drug development is ripe for innovation in the digital era and the expanded use of real-world evidence presents a clear enabler to saving time and money. It is true that RWD contains more potential bias as a result.

Clinical Trials 64

Clinical Trials Clinical Trials Life Science Trials 64

pharmaphorum

MAY 26, 2022

Racial disparities are still commonplace in many clinical trials with white-ethnic groups often overrepresented amongst trial participants. Inadequate clinical trial representations of all populations can therefore leave underrepresented groups vulnerable due to the lack of subgroup-specific data.

Clinical Trials 131

Clinical Trials Clinical Trials Trials Medicine 131

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. The earlier HTAs, researchers and pharma companies can start that engagement the better.

Drugs 98

Drugs Pharma Companies Licensing Licensing 98

pharmaphorum

AUGUST 24, 2022

Diversity in clinical trials is a “scientific imperative”, but how can industry bridge the gap between “why” and “how”? Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Clinical trial participation, she went on, was vital.

Clinical Trials 95

Clinical Trials Clinical Trials Trials Development 95

XTalks

FEBRUARY 17, 2021

And on February 19, join An Insider’s Look: How Syneos Health is Shortening the Distance from Lab to Life in Clinical Trials for key industry HR insights for jobseekers. The company is focused on helping develop and deliver therapeutics to patients by leading clinical trials globally.

Life Science 97

Life Science HR Clinical Research Clinical Trials 97

pharmaphorum

FEBRUARY 26, 2021

We take a look at efforts from charities, the government and digital innovators to boost awareness of rare conditions among GPs and make the clinical pathway smoother for patients. Inside the UK’s leading efforts to restart clinical research. Centessa’s founder on the new company’s unique R&D model.

Development 57

Development Research Pharma Companies Vaccination 57

Cloudbyz

MAY 19, 2021

According to Frost & Sullivan reports, more than 400 cell and gene therapies were under trial in the preclinical and phase 3 in 2017-2018 , which later witnessed a 27% Y.O.Y. However, the major challenge is the newness and uncharted territory of the CGT field for service companies.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. According to Hampleton Patners’ latest Healthtech M&A market report2, digital health companies raised a total of $57.2

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

Advarra

JUNE 14, 2022

Often, low accrual or delays in clinical trials stem from an undersized pipeline of potential participants. When site staff must manually find participants for trials, or even when automated recruitment solutions don’t deliver as promised, it puts the trial’s viability at stake, with sites and sponsors in the hot seat.

Trials 52

Trials Clinical Trials Clinical Trials Research 52

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. Dr Jay Mei has nearly 30 years of experience in clinical research and development of oncology therapeutics globally. About the interviewee.

Marketing 104

Marketing Drugs Regulation Development 104

pharmaphorum

MAY 18, 2022

At the height of the COVID-19 pandemic, these capabilities were put to the test, being used to compare hospital caseloads to research activity in real-time and enabling COVID-19 clinical trials to rapidly recruit participants across the UK. It would be fantastic if we could shift that paradigm when we are talking about research.

Research 72

Research Clinical Research Trials Pharma Companies 72

pharmaphorum

NOVEMBER 3, 2022

Beyond digital clinical measures, digital solutions are maturing to address major challenges facing clinical research and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. Pharma companies with more mature digital strategies are able to focus on questions of scale.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Medicine 80

pharmaphorum

APRIL 7, 2021

With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharma companies and will aim to keep more product rights than it did in the past.

Antibody 65

Antibody Life Science Development Regulation 65

Pharmaceutical Technology

MARCH 17, 2023

This is partly due to the differing business models used by pharma companies and digital therapeutic developers. According to Anguera, the field is in its infancy, particularly when it comes to testing approaches in clinical trials. Securing reimbursement for digital therapeutics also continues to impede its uptake.

Production 278

Production Development Pharma Companies Marketing 278